NFE2L2 and metabolic dysfunction-associated steatotic liver disease: Nrf2 activators are anticipated to have broader applications, as they are considered potential therapeutic agents not only for neurodegenerative diseases but also for non-alcoholic fatty liver disease and periodontal disease [119,120].